These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 37803043)
1. Amino acid transporter SLC38A5 is a tumor promoter and a novel therapeutic target for pancreatic cancer. Sniegowski T; Rajasekaran D; Sennoune SR; Sunitha S; Chen F; Fokar M; Kshirsagar S; Reddy PH; Korac K; Mahmud Syed M; Sharker T; Ganapathy V; Bhutia YD Sci Rep; 2023 Oct; 13(1):16863. PubMed ID: 37803043 [TBL] [Abstract][Full Text] [Related]
2. SLC38A5 Modulates Ferroptosis to Overcome Gemcitabine Resistance in Pancreatic Cancer. Kim MJ; Kim HS; Kang HW; Lee DE; Hong WC; Kim JH; Kim M; Cheong JH; Kim HJ; Park JS Cells; 2023 Oct; 12(20):. PubMed ID: 37887353 [TBL] [Abstract][Full Text] [Related]
3. Deletion of Slc6a14 reduces cancer growth and metastatic spread and improves survival in KPC mouse model of spontaneous pancreatic cancer. Schniers BK; Wachtel MS; Sharma M; Korac K; Rajasekaran D; Yang S; Sniegowski T; Ganapathy V; Bhutia YD Biochem J; 2022 Mar; 479(5):719-730. PubMed ID: 35212370 [TBL] [Abstract][Full Text] [Related]
4. Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation. Quan L; Ohgaki R; Hara S; Okuda S; Wei L; Okanishi H; Nagamori S; Endou H; Kanai Y J Exp Clin Cancer Res; 2020 Nov; 39(1):266. PubMed ID: 33256804 [TBL] [Abstract][Full Text] [Related]
5. Expression and function of SLC38A5, an amino acid-coupled Na+/H+ exchanger, in triple-negative breast cancer and its relevance to macropinocytosis. Ramachandran S; R Sennoune S; Sharma M; Thangaraju M; V Suresh V; Sneigowski T; D Bhutia Y; Pruitt K; Ganapathy V Biochem J; 2021 Nov; 478(21):3957-3976. PubMed ID: 34704597 [TBL] [Abstract][Full Text] [Related]
6. The Taurino G; Chiu M; Bianchi MG; Griffini E; Bussolati O Am J Physiol Cell Physiol; 2023 Aug; 325(2):C550-C562. PubMed ID: 37458433 [No Abstract] [Full Text] [Related]
8. Fructose-Induced mTORC1 Activation Promotes Pancreatic Cancer Progression through Inhibition of Autophagy. Cui Y; Tian J; Wang Z; Guo H; Zhang H; Wang Z; Liu H; Song W; Liu L; Tian R; Zuo X; Ren S; Niu R; Zhang F Cancer Res; 2023 Dec; 83(24):4063-4079. PubMed ID: 37738413 [TBL] [Abstract][Full Text] [Related]
9. Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer. De Santis MC; Gozzelino L; Margaria JP; Costamagna A; Ratto E; Gulluni F; Di Gregorio E; Mina E; Lorito N; Bacci M; Lattanzio R; Sala G; Cappello P; Novelli F; Giovannetti E; Vicentini C; Andreani S; Delfino P; Corbo V; Scarpa A; Porporato PE; Morandi A; Hirsch E; Martini M Gut; 2023 Feb; 72(2):360-371. PubMed ID: 35623884 [TBL] [Abstract][Full Text] [Related]
10. Amino acid transporter SLC38A5 regulates developmental and pathological retinal angiogenesis. Wang Z; Yemanyi F; Blomfield AK; Bora K; Huang S; Liu CH; Britton WR; Cho SS; Tomita Y; Fu Z; Ma JX; Li WH; Chen J Elife; 2022 Dec; 11():. PubMed ID: 36454214 [TBL] [Abstract][Full Text] [Related]
11. SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer. Shen X; Wang G; He H; Shang P; Yan B; Wang X; Shen W Breast Cancer; 2024 Jan; 31(1):96-104. PubMed ID: 37914960 [TBL] [Abstract][Full Text] [Related]
13. Roles of autophagy and metabolism in pancreatic cancer cell adaptation to environmental challenges. Maertin S; Elperin JM; Lotshaw E; Sendler M; Speakman SD; Takakura K; Reicher BM; Mareninova OA; Grippo PJ; Mayerle J; Lerch MM; Gukovskaya AS Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G524-G536. PubMed ID: 28705806 [TBL] [Abstract][Full Text] [Related]
14. Genetic Ablation of the Cystine Transporter xCT in PDAC Cells Inhibits mTORC1, Growth, Survival, and Tumor Formation via Nutrient and Oxidative Stresses. Daher B; Parks SK; Durivault J; Cormerais Y; Baidarjad H; Tambutte E; Pouysségur J; Vučetić M Cancer Res; 2019 Aug; 79(15):3877-3890. PubMed ID: 31175120 [TBL] [Abstract][Full Text] [Related]
15. Enhanced mitochondrial glutamine anaplerosis suppresses pancreatic cancer growth through autophagy inhibition. Jeong SM; Hwang S; Park K; Yang S; Seong RH Sci Rep; 2016 Aug; 6():30767. PubMed ID: 27477484 [TBL] [Abstract][Full Text] [Related]
16. Branched-chain amino acids sustain pancreatic cancer growth by regulating lipid metabolism. Lee JH; Cho YR; Kim JH; Kim J; Nam HY; Kim SW; Son J Exp Mol Med; 2019 Nov; 51(11):1-11. PubMed ID: 31784505 [TBL] [Abstract][Full Text] [Related]
17. RIOK3 promotes mTORC1 activation by facilitating SLC7A2-mediated arginine uptake in pancreatic ductal adenocarcinoma. Qin H; Sun R; Guo X; Fang L; Xu M; Teng Y; Zhen N; Wang A; Liu J Aging (Albany NY); 2023 Feb; 15(4):1039-1051. PubMed ID: 36880835 [TBL] [Abstract][Full Text] [Related]